e-learning resources

ERS International Congress, Milan 2017

Browse by day:
Saturday, 09.09.2017
Sunday, 10.09.2017
Monday, 11.09.2017
Tuesday, 12.09.2017
Wednesday, 13.09.2017

  

Sponsored symposia:

Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Novel molecular and genetic targets in COPD

Poster Discussion
Chairs: S. Sohal (Launceston, TAS, Australia), I. Vachier (Montpellier, France)
Late Breaking Abstract - Role of HIF2a oxygen sensing pathway in bronchial epithelium biology
M. Torres-Capelli (Madrid, Spain)
Congress or journal article abstract
Congress or journal article abstract
Late Breaking Abstract - Functional investigation of the corticosteroid resistance candidate FKBP5 using a CRISPR-Cas9 knockout model
A. Faiz (Groningen, Netherlands)
Congress or journal article abstract
Congress or journal article abstract
Does urinary peptide content differ between COPD patients with and without inherited alpha1-antitrypsin deficiency?
J. Chorostowska-Wynimko (Warszawa, Poland)
Congress or journal article abstract
Congress or journal article abstract
Transcriptomic and epigenetic changes in the lung of patients with severe COPD
M. Faner Canet (Barcelona, Spain)
Congress or journal article abstract
Congress or journal article abstract
Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases
L. Mur (Aberystwyth, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
PARK2-regulated mitophagy in COPD pathogenesis
N. Sato (Kumamoto, Japan)
Congress or journal article abstract
Congress or journal article abstract
Dual-phenotype mouse model of COPD study suggest combined therapy targeting G-CSF and IL-17A could treat COPD.
W. Lau (Melbourne, VIC, Australia)
Congress or journal article abstract
Congress or journal article abstract
The microbiome of COPD in protected, bronchoscopic airway samples
R. Grønseth (Morvik, Norway)
Congress or journal article abstract
Congress or journal article abstract
Type 2 diabetes-related “pulmonary insulin resistance” as a novel mechanism that complicates COPD phenotypes in mice
H. Nohara (kumamoto, Japan)
Congress or journal article abstract
Congress or journal article abstract
Serum neopterin and IL-6 as biomarkers in patients with COPD.
Y. Zhelyazkova (Stara Zagora, Bulgaria)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Telomere shortening and oxidative stress in patients with COPD
E. Cordoba-Lanus (Santa Cruz De Tenerife, Spain)
Congress or journal article abstract
Congress or journal article abstract
Integration at the network- and pathway level of multi-omics data from multiple anatomical locations facilitate COPD sub-phenotyping in small cohorts
A. Wheelock (Stockholm, Sweden)
Congress or journal article abstract
Congress or journal article abstract
Increased fatty acid oxidation impairs myoblast differentiation in hypercapnia
J. Sznajder (Chicago, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Exome sequencing in diseased and healthy subjects with a-1 antitrypsin deficiency
C. Rigobello (Padova, Italy)
Congress or journal article abstract
Congress or journal article abstract
Transforming growth factor alpha produces airway remodelling and reduces airway distensibility
K. Wang (Southern River, Australia)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Comparison of HSP mRNA relative levels in sputum of COPD patients and subjects exposed to wood smoke and/or cigarette smoke.
R. Falfán Valencia (Mexico, Mexico)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster